News Conference News ACC 2026 Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate Todd Neale April 02, 2026
News Conference News ACC 2026 Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering Michael O'Riordan April 01, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2026 Caitlin E. Cox April 01, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2026 Michael O'Riordan March 02, 2026
News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News TAVI Patients Seem to Pay No Penalty for Obstructive CAD Yael L. Maxwell December 09, 2025
News Conference News AHA 2025 Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR Caitlin E. Cox November 14, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Industry News Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients September 15, 2025
News Conference News ESC 2025 ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients Michael O'Riordan September 10, 2025
News Daily News For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis Yael L. Maxwell August 14, 2025
News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Daily News Stress Testing Picks Up ‘Novel Risk Patterns’ in Stable CAD Patients: ISCHEMIA Caitlin E. Cox July 10, 2025
News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2025 Caitlin E. Cox April 30, 2025
Presentation ACC 2025 Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial Presenter: Joo-Yong Hahn March 29, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025